- Tools for Investors
- Stock News
- Investing Ideas
- Econ & Policy
- Personal Finance
Baker Mark Robert who is CEO at Progenics Pharmaceuticals Inc. (NASDAQ:PGNX), bought 1,215 shares at $2.82 per share for a total value of $3,429. The shares recently traded at $2.94, up $0.12, or 4.26% since the insider buy.
Current Price $2.94
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
There's always a bull market in some sector! Find the best opportunities in commodities.